Serge Harb is a Cardiology physician affiliated with Cleveland Clinic. OpenAlex indexes 422 publications with 4,584 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
216-444-2200Registry record last updated 15 Sept 2018.
Clinical trials
- Intracardiac Echocardiography Guided Watchman Device Implant
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202531 payments$37,091openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202521 payments$12,855openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.6%Statin29.8%Atorvastatin Calcium67%Rosuvastatin Calcium33%Part D≥14 patientsBeta blocker26.7%Metoprolol Succinate56%Carvedilol23%Metoprolol Tartrate21%Part D<11 patients+ 4 more classes in this area
Blood & clotting
13.4%Factor Xa inhibitor13.4%Eliquis63%Xarelto37%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Initial Experience and Bench Validation of the CLEVE Prosthetic Leaflet Modification Procedure During Aortic and Mitral Valve-in-Valve Procedures
JACC: Cardiovascular Interventions
2025 - Transcatheter Valve Replacement in Severe Tricuspid Regurgitation
New England Journal of Medicine
2024 - Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling
Journal of the American College of Cardiology
2024 - Incidence, Risk Factors, and Outcomes Associated With Permanent Pacemaker Implantation Following Tricuspid Valve Surgery
Journal of the American Heart Association
2024 - Effectiveness of Pre-TAVR CTA as a Screening Tool for Significant CAD Before TAVR
JACC: Cardiovascular Interventions
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”